Active Ingredient(s): Doxapram
FDA Approved: * June 23, 1965
Pharm Company: * BAXTER HLTHCARE
Category: Respiratory Failure

Doxapram hydrochloride (marketed as Dopram, Stimulex or Respiram) is a respiratory stimulant. Administered intravenously, doxapram stimulates an increase in tidal volume, and respiratory rate. Contents 1 Mechanism of action 2 Appearance 3 Uses 4 Side effects 5 See also 6 References Mechanism of action A vial of doxapram Doxapram stimulates chemoreceptors in the carotid bodies of the carotid arteries, which in turn, stimulates the respiratory centre in the brain stem. Appearance D... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Dopram 20 mg/ml Intravenous Injection
NDC: 0641-6018
West-ward Pharmaceutical Corp.
Dopram 20 mg/ml Intravenous Injection
NDC: 60977-144
Baxter Healthcare Corporation